Calendar · pharmadog

Sign In Subscribe

Date TBD

50

RECRUITINGphase readoutNCT06931340: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE3. Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07667868: A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BP2202 in Patients With Relapsed/Refractory Multiple Myeloma

Sponsor: BrightPath Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (RRMM)

full page →ctgov ↗

COMPLETEDphase readoutNCT07236268: Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia

Sponsor: Comenius University. Phase: . Conditions: STIs, HIV, Rapid Detection

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05621850: Impact of CErebral Endovascular PROcedures on the Systemic Immune responSe Response

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Cerebral Arterio-venous Malformation

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07571291: DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Pulmonary Fibrosis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06094491: Virtual Diabetes Group Visits Across Health Systems

Sponsor: University of Chicago. Phase: NA. Conditions: T2DM (Type 2 Diabetes Mellitus), Hypertension, Heart Disease Chronic, Stroke, Hyperlipidemias, Peripheral Vascular Diseases, Obesity

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07260760: Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke

Sponsor: Qianfoshan Hospital. Phase: . Conditions: Acute Ischemic Stroke

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07493460: Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines

Sponsor: Washington University School of Medicine. Phase: PHASE4. Conditions: Immunology, Healthy Adults

full page →ctgov ↗

COMPLETEDphase readoutNCT04273360: Restrictive Use of Restraints and Delirium Duration in ICU

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Restraint, Physical, Mechanical Ventilation

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07414160: Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients

Sponsor: The First Hospital of Jilin University. Phase: . Conditions: ICU, Critical Illness, Adult

full page →ctgov ↗

RECRUITINGphase readoutNCT07588360: Haplo-Cord HSCT for AML/MDS

Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia)

full page →ctgov ↗

COMPLETEDphase readoutNCT05304715: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Sponsor: Hellenic Institute for the Study of Sepsis. Phase: PHASE2. Conditions: Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality

full page →ctgov ↗

COMPLETEDphase readoutNCT07363915: Group Program vs Single-Session Depathologizing Intervention for Subthreshold Anxiety-Depression in Primary Care (Spain)

Sponsor: University of Alcala. Phase: NA. Conditions: Anxiety, Depressive Symptoms, Anxiety Symptoms, Subthreshold Depression

full page →ctgov ↗

RECRUITINGphase readoutNCT06453525: PrediSuisse: Automatized Assessment of Difficult Airway

Sponsor: Centre Hospitalier Universitaire Vaudois. Phase: . Conditions: Anesthesia, Intubation; Difficult or Failed, Airway Complication of Anesthesia

full page →ctgov ↗

RECRUITINGphase readoutNCT05036226: COAST Therapy in Advanced Solid Tumors and Prostate Cancer

Sponsor: Medical University of South Carolina. Phase: PHASE1. Conditions: Prostate Cancer Recurrent, Solid Tumor, Adult

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03965689: Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Lung Non-Small Cell Squamous Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8, Stage IVB Lung Cancer AJCC v8, Unresectable Lung Non-Small Cell Carcinoma, Unresectable Lung Non-Squamous Non-Small Cell Carcinoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07661368: Cooking Health-Oriented Meals to Prevent Dementia and Diabetes

Sponsor: Virginia Polytechnic Institute and State University. Phase: NA. Conditions: Type 2 Diabetes, Dementia

full page →ctgov ↗

RECRUITINGphase readoutNCT07227168: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Sponsor: Sutro Biopharma, Inc.. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC, Non-Small Cell Lung Cancer NSCLC, Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Cervical Cancer, Endometrial Cancer, Urothelial Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05983068: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Sponsor: Sanofi. Phase: PHASE4. Conditions: Dermatitis Atopic

full page →ctgov ↗

COMPLETEDphase readoutNCT03531450: Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Gastroparesis

full page →ctgov ↗

COMPLETEDphase readoutNCT01833650: The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer

Sponsor: Cyprus University of Technology. Phase: NA. Conditions: Thyroid Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT05022550: Virtual-reality and Emotion Regulation in Violence-Exposed Youth

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Emotional Regulation, Adolescent Behavior

full page →ctgov ↗

RECRUITINGphase readoutNCT05845450: Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)

Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE2. Conditions: Colorectal Cancer, Resectable Colorectal Carcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07346391: Augmentation of Peri-implant Keratinized Mucosa Using a Combination of Free Gingival Graft Strip With Platelet-Rich Fibrin

Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City. Phase: NA. Conditions: Dental Implants

full page →ctgov ↗

RECRUITINGphase readoutNCT06902974: Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Sponsor: Sunstone Medical. Phase: PHASE2. Conditions: Post Traumatic Stress Disorder, PTSD

full page →ctgov ↗

COMPLETEDphase readoutNCT04991974: Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine

Sponsor: Friends Research Institute, Inc.. Phase: PHASE2. Conditions: Opioid-use Disorder

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07203274: The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

Sponsor: Aalborg University. Phase: NA. Conditions: Itchiness

full page →ctgov ↗

COMPLETEDphase readoutNCT00081874: RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Leukemia, Mantle Cell Lymphoma, Myelofibrosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07452874: Community-Based Occupational Therapy for Syrian Refugees to Improve Social Participation and Occupational Justice

Sponsor: Kocaeli University. Phase: NA. Conditions: Refugees, Occupational Injustice

full page →ctgov ↗

RECRUITINGphase readoutNCT07532018: DXP-106 in Solid Tumor Patients.

Sponsor: Singlomics Biopharmaceuticals Zhuhai Co., Ltd.. Phase: PHASE1. Conditions: Solid Tumor, Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07695818: Testing and Evaluation of the Returning to the Land Intervention to Address and Prevent Substance Misuse

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Substance Use, Children, Cultural Factors

full page →ctgov ↗

COMPLETEDphase readoutNCT05766813: Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Sponsor: Intra-Cellular Therapies, Inc.. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07092813: Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Sponsor: Iterum Therapeutics, International Limited. Phase: PHASE1. Conditions: Pharmacokinetics After Oral Intake

full page →ctgov ↗

COMPLETEDphase readoutNCT05760313: A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide

Sponsor: AbbVie. Phase: PHASE2. Conditions: Functional Constipation

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06740110: Bone Material's Histomorphometric Analysis In Socket Preservation

Sponsor: Medical Inventi S.A.. Phase: NA. Conditions: Socket Preservation

full page →ctgov ↗

COMPLETEDphase readoutNCT02838420: A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT04433520: Trevisio Post-Approval Study

Sponsor: Abbott Medical Devices. Phase: . Conditions: PFO - Patent Foramen Ovale, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PIVSD - Post Infarct Muscular Ventricular Septal Defect

full page →ctgov ↗

COMPLETEDphase readoutNCT07366320: Effects of Four-Week Rhodiola Rosea Supplementation on Physical Fitness, Neuromuscular Performance, and Decision-Making in Competitive Football Players

Sponsor: Beijing Sport University. Phase: NA. Conditions: Physical Performance and Fatigue in Competitive Football Players

full page →ctgov ↗

COMPLETEDphase readoutNCT02220920: Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Sponsor: Tanabe Pharma Corporation. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗

COMPLETEDphase readoutNCT05552820: Electroacupuncture for Mild-to-moderate Dry Eye

Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian. Phase: NA. Conditions: Dry Eye

full page →ctgov ↗

RECRUITINGphase readoutNCT06821282: Surveillance of AMR in DRC

Sponsor: University of Oxford. Phase: . Conditions: Bacteremia

full page →ctgov ↗

RECRUITINGphase readoutNCT06315582: Surgical Approach to Uterine Septum

Sponsor: Northwestern University. Phase: NA. Conditions: Uterine Septum, Surgical Complication, Septum; Uterus, Treatment Side Effects, Treatment

full page →ctgov ↗

AVAILABLEphase readoutNCT06751524: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Sponsor: Agenus Inc.. Phase: . Conditions: Colorectal Cancer (CRC), Pancreatic Cancer, Non-Small Cell Lung Cancer (NSCLC), Hepatocellular Carcinoma (HCC), Melanoma, Sarcoma, Ovarian Cancer, Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07480824: To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Myelofibrosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07467824: Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer

Sponsor: European University Miguel de Cervantes. Phase: NA. Conditions: Breast Cancer, Breast Neoplasms

full page →ctgov ↗

COMPLETEDphase readoutNCT07352124: Rosemary Infusion for Hypertension With Hypertriglyceridemia

Sponsor: awatef Sassi. Phase: NA. Conditions: Hypertension With Hypertriglyceridemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06637423: A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Non-Muscle Invasive Bladder Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07400523: Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06776523: Boosting Refugee Integration Through Psychological Intervention

Sponsor: University of Zurich. Phase: NA. Conditions: Psychological Distress, PTSD, Trauma, Common Mental Health Problems

full page →ctgov ↗

RECRUITINGphase readoutNCT05411523: Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

Sponsor: Mayo Clinic. Phase: . Conditions: Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

full page →ctgov ↗